U.S. drug spending has increased dramatically in the last 20 years. Americans pay the highest drug prices in the world, which leads to higher direct spending for patients and payers—both in the private and government sectors. Meanwhile, health plans are forced to raise premiums or make benefits less generous as prices continue to skyrocket. In this paper, Abt authors highlight the causes of these increases, and identify possible strategies that the Center for Medicare & Medicaid Services (CMS) could pursue to combat the rise in prices. Additionally, previous work for CMS and others is cited to help illustrate how research and evaluations can help identify and validate strategies.
Read More
Health Policy & Systems in North America
Managing Opioid Use and Misuse in Older Adults
Older adults are twice as likely as the general population to have pain, and clinicians often rely on opioid treatment. As a result, opioid use, misuse, and opioid use disorder have increased among older adults, who are vulnerable to adverse reactions…
Evaluation of the ACO REACH Model
As part of a team with NORC, Abt conducted a mixed methods evaluation of the CMS ACO REACH Model and found savings and quality improvements.
Spotlight On: Primary Care
Abt’s experts partner with federal agencies, states, and other organizations to advance evidence-based primary care in the U.S.
Gerontological Society of America (GSA) 2024 Annual Scientific Meeting